Name | Number of supported studies | Average coverage | |
---|---|---|---|
non-classical monocyte | 6 studies | 22% ± 6% | |
classical monocyte | 4 studies | 21% ± 4% |
Insufficient scRNA-seq data for expression of OAS2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 98% | 1306.18 | 1419 / 1445 | 97% | 90.38 | 178 / 183 |
breast | 100% | 1519.73 | 458 / 459 | 93% | 77.32 | 1040 / 1118 |
lung | 100% | 2859.85 | 578 / 578 | 90% | 47.42 | 1034 / 1155 |
uterus | 93% | 633.58 | 158 / 170 | 85% | 62.22 | 388 / 459 |
prostate | 95% | 846.93 | 233 / 245 | 78% | 31.12 | 390 / 502 |
bladder | 95% | 1062.52 | 20 / 21 | 76% | 49.57 | 384 / 504 |
stomach | 99% | 948.67 | 354 / 359 | 72% | 42.09 | 207 / 286 |
intestine | 94% | 919.25 | 912 / 966 | 67% | 29.99 | 352 / 527 |
kidney | 97% | 1190.06 | 86 / 89 | 59% | 20.02 | 532 / 901 |
thymus | 99% | 1171.94 | 647 / 653 | 56% | 14.11 | 341 / 605 |
skin | 76% | 478.92 | 1375 / 1809 | 76% | 49.48 | 358 / 472 |
ovary | 51% | 358.47 | 92 / 180 | 85% | 62.19 | 367 / 430 |
liver | 77% | 649.57 | 174 / 226 | 42% | 13.22 | 172 / 406 |
adrenal gland | 95% | 714.43 | 246 / 258 | 21% | 4.62 | 49 / 230 |
pancreas | 15% | 69.52 | 50 / 328 | 89% | 42.34 | 158 / 178 |
brain | 69% | 440.97 | 1828 / 2642 | 32% | 12.43 | 229 / 705 |
lymph node | 0% | 0 | 0 / 0 | 100% | 72.87 | 29 / 29 |
spleen | 100% | 5050.16 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 100% | 1869.41 | 1203 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 8566.59 | 914 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 89.85 | 44 / 45 |
heart | 96% | 774.69 | 825 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 87% | 878.30 | 1167 / 1335 | 0% | 0 | 0 / 0 |
muscle | 38% | 167.88 | 307 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 34% | 13.41 | 27 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006139 | Biological process | nucleobase-containing compound metabolic process |
GO_0045071 | Biological process | negative regulation of viral genome replication |
GO_0032728 | Biological process | positive regulation of interferon-beta production |
GO_0009615 | Biological process | response to virus |
GO_0051607 | Biological process | defense response to virus |
GO_0006401 | Biological process | RNA catabolic process |
GO_0060700 | Biological process | regulation of ribonuclease activity |
GO_0060337 | Biological process | type I interferon-mediated signaling pathway |
GO_0042742 | Biological process | defense response to bacterium |
GO_0032760 | Biological process | positive regulation of tumor necrosis factor production |
GO_0070106 | Biological process | interleukin-27-mediated signaling pathway |
GO_1903487 | Biological process | regulation of lactation |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0016020 | Cellular component | membrane |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0046872 | Molecular function | metal ion binding |
GO_0005524 | Molecular function | ATP binding |
GO_0001730 | Molecular function | 2'-5'-oligoadenylate synthetase activity |
GO_0005515 | Molecular function | protein binding |
GO_0003725 | Molecular function | double-stranded RNA binding |
Gene name | OAS2 |
Protein name | 2'-5'-oligoadenylate synthetase 2, 69/71kDa 2'-5' oligoadenylate synthase (EC 2.7.7.84) 2'-5'-oligoadenylate synthase 2 ((2-5')oligo(A) synthase 2) (2-5A synthase 2) (EC 2.7.7.84) (p69 OAS / p71 OAS) (p69OAS / p71OAS) 2'-5'-oligoadenylate synthetase 2 |
Synonyms | |
Description | FUNCTION: Interferon-induced, dsRNA-activated antiviral enzyme which plays a critical role in cellular innate antiviral response . Activated by detection of double stranded RNA (dsRNA): polymerizes higher oligomers of 2'-5'-oligoadenylates (2-5A) from ATP which then bind to the inactive monomeric form of ribonuclease L (RNASEL) leading to its dimerization and subsequent activation . Activation of RNASEL leads to degradation of cellular as well as viral RNA, resulting in the inhibition of protein synthesis, thus terminating viral replication . Can mediate the antiviral effect via the classical RNASEL-dependent pathway or an alternative antiviral pathway independent of RNASEL . In addition, it may also play a role in other cellular processes such as apoptosis, cell growth, differentiation and gene regulation . May act as a negative regulator of lactation, stopping lactation in virally infected mammary gland lobules, thereby preventing transmission of viruses to neonates (By similarity). Non-infected lobules would not be affected, allowing efficient pup feeding during infection (By similarity). . |
Accessions | ENST00000552756.6 Q7Z6D0 A0A087X0V5 ENST00000342315.8 [P29728-1] ENST00000680514.1 F8VPI5 A0A7P0TAE6 ENST00000680138.1 A0A7P0TAV1 ENST00000680122.1 A0A7P0T9B5 ENST00000680685.1 ENST00000392583.7 [P29728-2] A0A7P0T8H9 ENST00000449768.2 [P29728-3] ENST00000679877.1 ENST00000551603.2 P29728 F8W1C5 ENST00000620097.2 |